Navigation Links
Dr. Benjamin Raab of Naperville, IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

NAPERVILLE, Ill., July 10 /PRNewswire/ -- Benjamin J. Raab, M.D., head of Dermatology & Cosmetic Skin Surgery, has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines, to treat patients who are looking for a longer lasting dermal filler. Dr. Raab has treated over 150 patients with Artefill the past several years due to its proven success and effectiveness for the correction of wrinkles.

"Artefill is a paradigm shift in our thinking from temporary to long lasting fillers for wrinkle correction," said Benjamin J. Raab, M.D. "This breakthrough product has proven to be more effective than any other filler product to address a patient's desire for long lasting, natural feeling wrinkle correction."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide a scaffold for the patient's own collagen stimulation to generate long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in Illinois and is not available at all physician offices. Dr. Raab is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the product.

A female patient of Dr. Raab's said, "What a natural transformation! It was a subtle change which produced extremely positive feedback. Artefill performed above and beyond my expectations and naturally recreated the youthful silhouette around my mouth. I am extremely pleased with the results!"

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10,000 patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit or

About Benjamin J. Raab, M.D.:

Dr. Benjamin J. Raab is head of Dermatology & Cosmetic Skin Surgery based in Naperville, IL. He specializes in the most up-to-date advances in Laser Skin Resurfacing and Rejuvenation to reduce wrinkles, facial redness, discoloration and acne, as well as Artefill. Dr. Raab was the first to offer many of these breakthrough techniques in DuPage County, and provide training on these techniques to other doctors. He currently serves as Assistant Professor of Clinical Dermatology at Northwestern University Medical School and is on the medical staff of Edward Hospital, Naperville, Rush Copley Hospital, Aurora and Northwestern Memorial Hospital, Chicago. He is also the author or co-author of twelve scientific journal articles, a medical textbook chapter, and has been a reviewer for the Journal of the American Academy of Dermatology and the Journal of the American Medical Association. For more information visit

ATTENTION MEDIA: To download Artefill patient before and after pictures visit or

    Dr. Benjamin J. Raab
    (630) 499-8999

SOURCE Dermatology & Cosmetic Skin Surgery
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
2. Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman
3. The Benjamin Marks National Sleep Awareness Week With Introduction Of "The Sleep Retreat"
4. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
5. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
6. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
7. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
8. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
9. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
10. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
11. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
Post Your Comments:
(Date:11/27/2015)... ... , ... There is only one major question facing all law firms in ... question has not been an easy question to answer. Especially when the senior partners ... workforce don’t share the same discipline around working long hours. , In addition ...
(Date:11/27/2015)... ... 27, 2015 , ... According to an article published November 13th ... in Washington D.C. revolved around the fact that proper dental care, both at-home and ... the link between periodontal disease (more commonly referred to as gum disease) and diabetes. ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... care in America. As people age, more care is needed, especially with Alzheimer’s, ... and medical professionals are being overworked. The forgotten part of this equation: 80 ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , Nov. 27, 2015 Research and ... the "Global Intrauterine Devices Market 2015-2019" report ... --> In this report, the author the ... devices market for 2015-2019. To calculate the market size, ... following type of products: Hormonal IUDs and copper IUDs. ...
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
(Date:11/26/2015)... Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische ... ) --> ...      (Photo: ) ... Universitair Medisch Centrum (LUMC) blijkt ...
Breaking Medicine Technology: